Seth Lederman - 18 Mar 2026 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Chief Executive Officer, Director
Signature
/s/ Seth Lederman
Issuer symbol
TNXP
Transactions as of
18 Mar 2026
Net transactions value
+$223,350
Form type
4
Filing time
18 Mar 2026, 17:03:27 UTC
Previous filing
26 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LEDERMAN SETH Chief Executive Officer, Director C/O TONIX PHARMACEUTICALS HOLDING CORP, 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS /s/ Seth Lederman 18 Mar 2026 0001563420

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, $0.001 par value Purchase $223,350 +15,000 +1500000% $14.89 15,001 18 Mar 2026 By IRA Account F1
holding TNXP Common Stock, $0.001 par value 4,005 18 Mar 2026 Direct
holding TNXP Common Stock, $0.001 par value 1 18 Mar 2026 Lederman & Co. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person may be deemed a control person of this entity.